Cargando…

Blood Pressure and Chronic Kidney Disease Progression: An Updated Review

Hypertension (HTN) is common in chronic kidney disease (CKD), and it may aggravate CKD progression. The optimal blood pressure (BP) value in CKD patients is not established yet, although systolic BP ≤130 mmHg is acceptable as a target. Continuous BP monitoring is essential to detect the different va...

Descripción completa

Detalles Bibliográficos
Autores principales: Habas, Elmukhtar, Habas, Eshrak, Khan, Fahmi Y, Rayani, Amnna, Habas, Aml, Errayes, Mehdi, Farfar, Khalifa L, Elzouki, Abdel-Naser Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116515/
https://www.ncbi.nlm.nih.gov/pubmed/35602805
http://dx.doi.org/10.7759/cureus.24244
_version_ 1784710127851405312
author Habas, Elmukhtar
Habas, Eshrak
Khan, Fahmi Y
Rayani, Amnna
Habas, Aml
Errayes, Mehdi
Farfar, Khalifa L
Elzouki, Abdel-Naser Y
author_facet Habas, Elmukhtar
Habas, Eshrak
Khan, Fahmi Y
Rayani, Amnna
Habas, Aml
Errayes, Mehdi
Farfar, Khalifa L
Elzouki, Abdel-Naser Y
author_sort Habas, Elmukhtar
collection PubMed
description Hypertension (HTN) is common in chronic kidney disease (CKD), and it may aggravate CKD progression. The optimal blood pressure (BP) value in CKD patients is not established yet, although systolic BP ≤130 mmHg is acceptable as a target. Continuous BP monitoring is essential to detect the different variants of high BP and monitor the treatment response. Various methods of BP measurement in the clinic office and at home are currently used. One of these methods is ambulatory BP monitoring (ABPM), by which BP can be closely assessed for even diurnal changes. We conducted a non-systematic literature review to explore and update the association between high BP and the course of CKD and to review various BP monitoring methods to determine the optimal method for BP recording in CKD patients. PubMed, EMBASE, Google, Google Scholar, and Web Science were searched for published reviews and original articles on BP and CKD by using various phrases and keywords such as "hypertension and CKD", "CKD progression and hypertension", "CKD stage and hypertension", "BP control in CKD", "BP measurement methods", "diurnal BP variation effect on CKD progression", and "types of hypertension." We evaluated and discussed published articles relevant to the review objective. Before preparing the final draft of this article, each author was assigned a section of the topic to read, research deeply, and write a summary about the assigned section. Then a summary of each author's contribution was collected and discussed in several group sessions. Early detection of high BP is essential to prevent CKD development and progression. Although the latest Kidney Disease Improving Global Outcomes (KDIGO) guidelines suggest that a systolic BP ≤120 mmHg is the target toprevent CKD progression, systolic BP ≤130 mmHg is universally recommended.ABPM is a promising method to diagnose and follow up on BP control; however, the high cost of the new devices and patient unfamiliarity with them have proven to be major disadvantages with regard to this method.
format Online
Article
Text
id pubmed-9116515
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-91165152022-05-20 Blood Pressure and Chronic Kidney Disease Progression: An Updated Review Habas, Elmukhtar Habas, Eshrak Khan, Fahmi Y Rayani, Amnna Habas, Aml Errayes, Mehdi Farfar, Khalifa L Elzouki, Abdel-Naser Y Cureus Internal Medicine Hypertension (HTN) is common in chronic kidney disease (CKD), and it may aggravate CKD progression. The optimal blood pressure (BP) value in CKD patients is not established yet, although systolic BP ≤130 mmHg is acceptable as a target. Continuous BP monitoring is essential to detect the different variants of high BP and monitor the treatment response. Various methods of BP measurement in the clinic office and at home are currently used. One of these methods is ambulatory BP monitoring (ABPM), by which BP can be closely assessed for even diurnal changes. We conducted a non-systematic literature review to explore and update the association between high BP and the course of CKD and to review various BP monitoring methods to determine the optimal method for BP recording in CKD patients. PubMed, EMBASE, Google, Google Scholar, and Web Science were searched for published reviews and original articles on BP and CKD by using various phrases and keywords such as "hypertension and CKD", "CKD progression and hypertension", "CKD stage and hypertension", "BP control in CKD", "BP measurement methods", "diurnal BP variation effect on CKD progression", and "types of hypertension." We evaluated and discussed published articles relevant to the review objective. Before preparing the final draft of this article, each author was assigned a section of the topic to read, research deeply, and write a summary about the assigned section. Then a summary of each author's contribution was collected and discussed in several group sessions. Early detection of high BP is essential to prevent CKD development and progression. Although the latest Kidney Disease Improving Global Outcomes (KDIGO) guidelines suggest that a systolic BP ≤120 mmHg is the target toprevent CKD progression, systolic BP ≤130 mmHg is universally recommended.ABPM is a promising method to diagnose and follow up on BP control; however, the high cost of the new devices and patient unfamiliarity with them have proven to be major disadvantages with regard to this method. Cureus 2022-04-18 /pmc/articles/PMC9116515/ /pubmed/35602805 http://dx.doi.org/10.7759/cureus.24244 Text en Copyright © 2022, Habas et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Habas, Elmukhtar
Habas, Eshrak
Khan, Fahmi Y
Rayani, Amnna
Habas, Aml
Errayes, Mehdi
Farfar, Khalifa L
Elzouki, Abdel-Naser Y
Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
title Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
title_full Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
title_fullStr Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
title_full_unstemmed Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
title_short Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
title_sort blood pressure and chronic kidney disease progression: an updated review
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116515/
https://www.ncbi.nlm.nih.gov/pubmed/35602805
http://dx.doi.org/10.7759/cureus.24244
work_keys_str_mv AT habaselmukhtar bloodpressureandchronickidneydiseaseprogressionanupdatedreview
AT habaseshrak bloodpressureandchronickidneydiseaseprogressionanupdatedreview
AT khanfahmiy bloodpressureandchronickidneydiseaseprogressionanupdatedreview
AT rayaniamnna bloodpressureandchronickidneydiseaseprogressionanupdatedreview
AT habasaml bloodpressureandchronickidneydiseaseprogressionanupdatedreview
AT errayesmehdi bloodpressureandchronickidneydiseaseprogressionanupdatedreview
AT farfarkhalifal bloodpressureandchronickidneydiseaseprogressionanupdatedreview
AT elzoukiabdelnasery bloodpressureandchronickidneydiseaseprogressionanupdatedreview